EDMONTON, CANADA, May 18—Coming off the completion of their seed funding round, DrugBank is rapidly scaling up its team and attracting top talent for key roles, including a Vice President of Sales and Growth.
DrugBank has been steadily increasing their capacity, more than doubling their staff since March 2020 alone, as a means of staying on track with their ambitious growth trajectory. They’ve remained committed to balancing ambitious talent and culture fit which helped them secure a top 20 placement in the 2022 Best Work Places in Canada list.
“We are ramping up capacity across all teams and being extremely strategic to bring on the right individuals who can complement our already impressive team—while pushing us to the next level,” says Michael Wilson, DrugBank co-founder and CEO. “We’ve worked hard to build a strong team and culture, and we’re not going to compromise that.”
Among many of the exciting additions to DrugBank’s team, they recently welcomed their first Vice President of Sales and Growth, Andrew Capper. This vital role will be responsible for creating and executing a vision for continued scalable growth within the sales, partnership, marketing, and customer success teams. Andrew will also offer guidance and direction for these teams as they work together to strategize, set, and aggressively pursue growth targets.
“I look forward to lending my experience to this flourishing team,” remarked Andrew Capper. “DrugBank has demonstrated their deep commitment to their customers and I am eager to help push that even further by building up our strategic relationships and bolstering our team’s strengths.”
Profile photo of Andrew Capper
Andrew comes to DrugBank from Honeywell where he spent 24 years driving sales successes, eventually leading a $300M+ sales organization as the Senior Director of Sales. He brings with him a deep understanding of multinational sales, management excellence, and a background in life sciences.
DrugBank is set to continue hiring for key roles across the organization. Visit their careers page or follow them on social for the latest opportunities.
ABOUT DRUGBANK
DrugBank is the world’s first intelligent and comprehensive drug knowledge platform. Utilizing artificial intelligence, their team of experts gather, author, verify, and structure the latest biomedical information into one knowledge platform. This platform is accessible through DrugBank Online (their free-to-use website), and data and software integrations. DrugBank is honored to partner with the world’s leading biomedical researchers as they pursue their goal of better medical outcomes. www.drugbank.com
Press Inquiries:
Kelvin Chen
Marketing Director, DrugBank
kelvin@drugbank.com